Abstract
Purpose
Drug particle physical properties are critical for the efficiency of a drug delivered to the lung. The purpose of this study was to produce ultrafine sumatriptan succinate particles for inhalation.
Methods
Sumatriptan succinate particles were produced via reactive precipitation without any surfactants. Several low toxic organic solvents such as acetone, isopropanol, and tetrahydrofuran were investigated as the reaction medium. And the dry powder was obtained via spray drying. FT-IR, HPLC, SEM and XRD were exploited to characterize the physicochemical properties of the ultrafine sumatriptan succinate dry powder. The aerosol performance of the powder was evaluated using an Aeroliser®connected to a multi stage liquid impinger operating at 60 l/min.
Results
The mean particle size of the ultrafine sumatriptan succinate particles obtained under optimum conditions was in the range of 630∼679 nm and consequently they were in the respirable range. The spray-dried powder whose fine particle fraction was increased up to 50.6 ± 8.2% showed good aerosol performance whereas the vacuum-dried powder was approximate 18.2 ± 3.0%.
Conclusions
Good aerosol performance ultrafine sumatriptan succinate particles could be produced by reactive precipitation without any additives followed by spray drying at the optimum parameters.
References
S. S. Colman, M. I. Brod, A. Krishnamurthy, C. R. Rowland, K. J. Jirgens, and B. Gomez-Mantilla. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with Almotriptan or Sumatriptan. Clin. Ther. 23:127–145 (2001).
F. R. Taylor. Migraine headache: options for acute treatment. Curr. Neurol. Neurosci. Rep. 5:86–92 (2005).
N. T. Mathew, and E. W. Loder. Evaluating the triptans. Am. J. Med. Suppl 118:28S–35S (2005).
A. Femenía-Font, C. Balaguer-Fernández, V. Merino, and A. López-Castellano. Combination strategies for enhancing transdermal absorption of sumatriptan through skin. Int. J. Pharm. 323:125–130 (2006).
P. Tfelt-Hansen, P. De Vries, and P. R. Saxena. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 60:1259–1287 (2000).
R. J. Majithiya, P. K. Ghosh, M. L. Umrethia, and R. S. R. Murthy. Thermoreversible–mucoadhesive gel for nasal delivery of Sumatriptan. AAPS PharmSciTech. 7:E1–E7 (2006).
Y. Kato, K. Muraki, M. Fujitaka, N. Sakura, and K. Ueda. Plasma concentrations of disodium cromoglycate after various inhalation methods in healthy subjects. Br. J. Clin. Pharmacol. 48:154–157 (1999).
N. Rasenack, H. Steckel, and B. W. Müller. Preparation of microcrystals by in situ micronization. Powder Technol. 143144:291–296 (2004).
H. Steckel, N. Rasenack, and B. W. Müller. In-situ-micronization of disodium cromoglycate for pulmonary delivery. Eur. J. Pharm. Biopharm. 55:173–180 (2003).
M. J. Telko, and A. J. Hickey. Dry powder inhaler formulation. Respir. Care. 50:1209–1227 (2005).
C. C. Koch. Nanostructured materials-processing, properties and potential applications. William Andrew Publishing, Norwich, NY, 2002.
A. A. Date, and V. B. Patravale. Current strategies for engineering drug nanoparticles. Curr. Opin. Colloid. In. 9:222–235 (2004).
G. Nykamp, U. Carstensen, and B. W. Müller. Jet milling-a new technique for microparticle preparation. Int. J. Pharm. 242:79–86 (2002).
M. D. Ticehurst, P. A. Basford, C. I. Dallman, T. M. Lukas, P. V. Marshall, G. Nichols, and D. Smith. Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide. Int. J. Pharm. 193:247–259 (2000).
K. Brodka-Pfeiffer, P. Langguth, P. Graß, and H. Häusler. Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur. J. Pharm. Biopharm. 56:393–400 (2003).
J. F. Chen, M. Y. Zhou, L. Shao, Y. Y. Wang, J. Yun, N. Y. K. Chew, and H. K. Chan. Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int. J. Pharm. 269:267–274 (2004).
Z. Wang, J. F. Chen, Y. Le, Z. G. Shen, and J. Yun. Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation. Ind. Eng. Chem. Res. 46:4839–4845 (2007).
X. S. Li, J. X. Wang, Z. G. Shen, P. Y. Zhang, J. F. Chen, and J. Yun. Preparation of uniform prednisolone microcrystals by a controlled mcroprecipitaition method. Int. J. Pharm. 342:26–32 (2007).
J. F. Chen, Y. H. Wang, F. Guo, X. M. Wang, and C. Zheng. Synthesis of nanoparticles with novel technology: high gravity reactive precipitation. Ind. Eng. Chem. Res. 39:948–954 (2000).
T. Hu, H. Chiou, H. K. Chan, J. F. Chen, and J. Yun. Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation. J. Pharm. Sci. 97:932–937 (2008).
J. Elversson. Spray-dried powders for inhalation—particle formation and formulation concepts. Uppsala University, Sweden, 2005.
H. K. Chan, and N. Y. K. Chew. Novel alternative methods for the delivery of the drugs for the treatment of asthma. Adv. Drug Deliv. Rev. 55:793–805 (2003).
R. Vehring, and W. R. Foss. David Lechuga-Ballesteros. Particle formation in spray drying. J. Aerosol Sci. 38:728–746 (2007).
J. Y. Zhang, Z. G. Shen, J. Zhong, T. T. Hu, J. F. Chen, Z. Q. Ma, and J. Yun. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. Int. J. Pharm. 323:153–160 (2006).
Acknowledgments
This work was partially supported by the NSF of China (through Grant NO. 20325621).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, ZY., Le, Y., Hu, TT. et al. Production of Ultrafine Sumatriptan Succinate Particles for Pulmonary Delivery. Pharm Res 25, 2012–2018 (2008). https://doi.org/10.1007/s11095-008-9586-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9586-3